From: Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma
 | Group I (n = 30) | Group II (n = 30) | Group III (n = 30) | Test of sig. | p | |||
---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | |||
Sex | ||||||||
 Male | 16 | 53.3 | 19 | 63.3 | 17 | 56.7 | χ2 = 0.638 | 0.727 |
 Female | 14 | 46.7 | 11 | 36.7 | 13 | 43.3 | ||
Age (/years) | ||||||||
 Min.–max. | 50.0–76.0 | 50.0–78.0 | 23.0–69.0 | F = 1.946 | 0.149 | |||
 Mean ± SD | 59.23 ± 7.59 | 60.90 ± 7.84 | 56.53 ± 10.27 | |||||
 Median (IQR) | 57.0 (52.0–65.0) | 60.0 (55.0–65.0) | 57.0 (53.0–64.0) |